SAGE
Price
$9.15
Change
-$0.13 (-1.40%)
Updated
Jun 27 closing price
Capitalization
572.99M
36 days until earnings call
THRD
Price
$5.43
Change
-$0.02 (-0.37%)
Updated
Jun 27 closing price
Capitalization
245.04M
39 days until earnings call
Interact to see
Advertisement

SAGE vs THRD

Header iconSAGE vs THRD Comparison
Open Charts SAGE vs THRDBanner chart's image
Sage Therapeutics
Price$9.15
Change-$0.13 (-1.40%)
Volume$4.68M
Capitalization572.99M
Third Harmonic Bio
Price$5.43
Change-$0.02 (-0.37%)
Volume$736.04K
Capitalization245.04M
SAGE vs THRD Comparison Chart in %
Loading...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SAGE vs. THRD commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGE is a StrongBuy and THRD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (SAGE: $9.15 vs. THRD: $5.43)
Brand notoriety: SAGE and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SAGE: 280% vs. THRD: 267%
Market capitalization -- SAGE: $572.99M vs. THRD: $245.04M
SAGE [@Biotechnology] is valued at $572.99M. THRD’s [@Biotechnology] market capitalization is $245.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SAGE’s FA Score shows that 0 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • SAGE’s FA Score: 0 green, 5 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAGE’s TA Score shows that 5 TA indicator(s) are bullish while THRD’s TA Score has 2 bullish TA indicator(s).

  • SAGE’s TA Score: 5 bullish, 5 bearish.
  • THRD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than THRD.

Price Growth

SAGE (@Biotechnology) experienced а -1.61% price change this week, while THRD (@Biotechnology) price change was -0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

SAGE is expected to report earnings on Aug 05, 2025.

THRD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($573M) has a higher market cap than THRD($245M). SAGE YTD gains are higher at: 68.508 vs. THRD (-47.230). THRD has higher annual earnings (EBITDA): -66.25M vs. SAGE (-358.98M). SAGE has more cash in the bank: 424M vs. THRD (272M). THRD has less debt than SAGE: THRD (3M) vs SAGE (11.9M). SAGE has higher revenues than THRD: SAGE (47.4M) vs THRD (0).
SAGETHRDSAGE / THRD
Capitalization573M245M234%
EBITDA-358.98M-66.25M542%
Gain YTD68.508-47.230-145%
P/E RatioN/AN/A-
Revenue47.4M0-
Total Cash424M272M156%
Total Debt11.9M3M396%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SAGETHRD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
80%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GISOX18.460.13
+0.71%
Grandeur Peak Intl Stalwarts Inv
JMIGX24.700.17
+0.69%
Jacob Discovery Fd Instl
BTBFX62.770.27
+0.43%
Boston Trust Asset Management
PNOCX85.230.33
+0.39%
Putnam Sustainable Leaders C
VYSGX14.44N/A
N/A
Voya Small Company W

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with APGE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
-0.37%
APGE - THRD
42%
Loosely correlated
N/A
NVAX - THRD
42%
Loosely correlated
-1.92%
IGMS - THRD
41%
Loosely correlated
-11.48%
ACLX - THRD
36%
Loosely correlated
+0.90%
SAGE - THRD
34%
Loosely correlated
-1.40%
More